Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-old theories die hard

Rizwan Haq1

  • 1Division of Experimental Therapeutics, Ontario Cancer Institute, MD/PhD Program, Faculty of Medicine, University of Toronto, Toronto, Ont.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|July 16, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025.

Pigment cell & melanoma research·2026
Same author

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same author

Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

Molecular cancer therapeutics·2026
Same author

Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab Response.

Pigment cell & melanoma research·2025
Same author

Severity and progression of dermatologic adverse events associated with tebentafusp: A retrospective multicenter cohort study.

Journal of the American Academy of Dermatology·2025
Same author

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.

Cancer cell·2025